Friday, 20 October 2017

Partner 1: Paediatric European Network for Treatment of AIDS (PENTA)

www.penta-id.org

The Paediatric European Network for Treatment of AIDS (PENTA, www.pentatrials.org) was established in 1991 as collaboration between paediatric HIV centres in Europe to undertake independent clinical trials in HIV infected children since trials in adults were not sufficient. By December 2011, more than 80 clinical centres in 16 countries and nearly 1800 children had been enrolled in 15 major CTs. Within the 6th FP, the coordination of the European Collaborative Study (ECS), one of the largest cohorts of children born to HIV positive mothers, was merged with PENTA, thus creating a single centralised European network for research on paediatric HIV. Activities are now including not only clinical trials, but also cohort studies collaboration, pregnancy studies and training/educational programmes. Besides coordinating and taking part in several EU-funded projects on HIV-related issues (PENTA/ECS, PENTA LABNET, ACTIVATE, NEAT, CHAIN and EuroCOORD), PENTA has now broadened its scope shifting from paediatric research in HIV to interest in other infectious diseases thus becoming PENTA-ID (Paediatric European Network for the Treatment of AIDS and Infectious Diseases). In light of this expansion PENTA-ID has started making use of the expertise acquired in previous clinical trials by PENTA to conduct trials in neonatal sepsis and antibiotic therapy such as Neomero, a project evaluating PK, safety and efficacy of meropenem in neonates aiming for PUMA. In addition the network has been involved as key partner in GRIP, EMIF and ARPEC, To coordinate all these activities in May 2004 PENTA Foundation was set up. As per its statute, the Foundation is a promoter/sponsor of clinical trials according to the GCP guidelines and new relevant European Directives, a centre for the collection, study, research and dissemination of information on HIV and infectious diseases and coordinator of training programmes for health providers. The founder members have been working together and running the PENTA network since 1991 and represent key institutions for PENTA activities such as Dipartimento di Pediatria of Padova, ANRS/INSERM SC10 HIV Trial Unit, Paris, MRC- CTU, London, Necker Hospital, Paris and University of Padova. Since 2008 PENTA has been formally present within the EMA Paediatric Committee (PDCO) as scientific and research organisation.

Copyright © NeoVanc | All rights reserved. Read the disclaimer.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no: 602041
Call: FP7-HEALTH-2013-INNOVATION-1
Privacy policy | Cookie policy

E-mail: website@neovanc.org